External validators converging: multiple independent outside parties have recently, concretely endorsed the company with
The model's full reasoning — Q2 2023 call → NO我们根据提供的财报电话会议记录来回答。问题问的是:管理层是否描述了不止一个独立的外部方最近以具体行动支持公司(资金、订单、产能、声誉、批准或合作),并且管理层是否将这些外部认可视为验证了一个其贡献仍主要在未来报告结果中的轨迹。需要回答YES或NO。 从记录中,我们看到: - 与Janssen(强生)的全球许可协议:Janssen支付了3000万美元前期现金许可费,并可能提供3000万美元实物支持、3000万美元股权(已收到500万美元),以及里程碑付款。这是明确的外部方行动。 - 与MD Anderson的合作:多个临床试验正在进行,包括胰腺癌、肺癌等。MD Anderson是独立的外部方,正在进行试验,但这是合作研究,不是资金投入。 - 与LianBio的协议:提到LianBio参与五个注册试验,并已产生收入(130万欧元)。但记录中未明确LianBio最近的具体行动,只是提到合同存在。 - 欧洲投资银行(EIB)的债务融资协议,正在讨论修改条款,但这是债务,不是外部投资。 问题要求至少两个独立的外部方在最近几个季度采取了具体行动(签署、订购、支付、部署、批准、投资、承诺),而不是表达兴趣。Janssen是明确的,有资金投入。MD Anderson是合作方,但他们的行动是开展临床试验,这算是一种承诺吗?记录中描述MD Anderson正在进行多项试验,并预期数据,但这是合作研究,不是商业承诺。LianBio的协议是之前签署的,但记录中未提及最近的具体行动。 管理层是否将这些视为验证轨迹?在记录中,管理层强调Janssen合作是“validate our platform”,并提到多个里程碑。但只有Janssen是明确的资金投入。MD Anderson是学术合作,不是商业投资。LianBio是之前的协议,未提及近期行动。 因此,只有Janssen一个外部方有具体资金行动。MD Anderson是合作,但未提及他们投入了资金或资源(虽然他们进行试验,但那是合作的一部分,不是独立投资)。所以不符合“至少两个独立外部方”的条件。 因此答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| MMLP | Martin Midstream Partners L.P. | Q2 2024 | 2024-07-18 | B |
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| ERO | Ero Copper Corp. | Q1 2024 | 2024-05-10 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| WEC | WEC Energy Group, Inc. | Q1 2024 | 2024-05-01 | A |
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| NICE | NICE Ltd. | Q4 2023 | 2024-02-22 | B+ |
| HP | Helmerich & Payne, Inc. | Q1 2024 | 2024-01-30 | C |
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| ICCM | IceCure Medical Ltd | Q3 2023 | 2023-11-15 | D |
| AIRG | Airgain, Inc. | Q3 2023 | 2023-11-09 | F |
| EFXT | Enerflex Ltd. | Q3 2023 | 2023-11-09 | C+ |
| NVAX | Novavax, Inc. | Q3 2023 | 2023-11-09 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| AEP | American Electric Power Company, Inc. | Q3 2023 | 2023-11-02 | C+ |
| APAM | Artisan Partners Asset Management Inc. | Q3 2023 | 2023-11-01 | C+ |
| DXLG | Destination XL Group, Inc. | Q2 2023 | 2023-08-24 | D |
| KMDA | Kamada Ltd. | Q2 2023 | 2023-08-16 | B+ |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| SITM | SiTime Corporation | Q2 2023 | 2023-08-02 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| IMAX | IMAX Corporation | Q2 2023 | 2023-07-26 | B+ |
| GVP | GSE Systems, Inc. | Q1 2023 | 2023-05-15 | D |
| PFIE | Profire Energy, Inc. | Q1 2023 | 2023-05-13 | B |
| SPIR | Spire Global, Inc. | Q1 2023 | 2023-05-10 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| CRBG | Corebridge Financial, Inc. | Q4 2022 | 2023-02-22 | B |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| ARWR | Arrowhead Pharmaceuticals, Inc. | Q4 2022 | 2022-11-28 | D |
| CUE | Cue Biopharma, Inc. | Q3 2022 | 2022-11-14 | D |
| BLZE | Backblaze, Inc. | Q3 2022 | 2022-11-11 | D |
| ICL | ICL Group Ltd | Q3 2022 | 2022-11-09 | B+ |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| AWRE | Aware, Inc. | Q3 2022 | 2022-10-30 | F |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| DM | Desktop Metal, Inc. | Q2 2022 | 2022-08-08 | F |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| SOPH | SOPHiA GENETICS SA | Q4 2021 | 2022-03-15 | C |
| CDXC | ChromaDex Corporation | Q4 2021 | 2022-03-09 | C+ |
| KD | Kyndryl Holdings, Inc. | Q4 2021 | 2022-03-01 | C+ |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
| ALHC | Alignment Healthcare, Inc. | Q3 2021 | 2021-11-06 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| WMB | The Williams Companies, Inc. | Q3 2021 | 2021-11-02 | B |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| LOPE | Grand Canyon Education, Inc. | Q2 2021 | 2021-08-08 | C |
| UFI | Unifi, Inc. | Q4 2021 | 2021-08-07 | B |
| CRS | Carpenter Technology Corporation | Q4 2021 | 2021-08-01 | A |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| TENB | Tenable Holdings, Inc. | Q2 2021 | 2021-07-27 | A |
| ADSK | Autodesk, Inc. | Q3 2019 | 2018-11-20 | A |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| HPE | Hewlett Packard Enterprise Company | Q2 2018 | 2018-05-22 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| ACHC | Acadia Healthcare Company, Inc. | Q4 2017 | 2018-02-22 | C+ |
| EPAM | EPAM Systems, Inc. | Q4 2017 | 2018-02-16 | B |
| INST | Instructure's | Q4 2017 | 2018-02-12 | B+ |
| UNH | UnitedHealth Group Incorporated | Q4 2017 | 2018-01-16 | A |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| MITK | Mitek Systems, Inc. | Q4 2017 | 2017-11-07 | C+ |
| MKTX | MarketAxess Holdings Inc. | Q3 2017 | 2017-10-25 | C+ |
| HSTM | HealthStream, Inc. | Q3 2017 | 2017-10-24 | C |
| GNTX | Gentex Corporation | Q3 2017 | 2017-10-20 | B |
| MXL | MaxLinear, Inc. | Q2 2017 | 2017-08-08 | C+ |
| CNS | Cohen & Steers, Inc. | Q2 2017 | 2017-07-20 | B |
| PTC | PTC Inc. | Q3 2017 | 2017-07-19 | C+ |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| BP | BP p.l.c. | Q4 2016 | 2017-02-07 | B+ |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
| TGI | Triumph Group, Inc. | Q2 2017 | 2016-11-03 | C+ |
| NTCT | NetScout Systems, Inc. | Q2 2017 | 2016-10-27 | D |
| ARAY | Accuray Incorporated | Q4 2016 | 2016-08-17 | B |
| GES | Guess?, Inc. | Q1 2017 | 2016-05-25 | F |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| SPR | Spirit AeroSystems Holdings, Inc. | Q1 2016 | 2016-04-29 | D |
| ACCO | ACCO Brands Corporation | Q1 2016 | 2016-04-27 | B+ |
| WK | Workiva Inc. | Q4 2015 | 2016-03-01 | B |
| HPP | Hudson Pacific Properties, Inc. | Q4 2015 | 2016-02-25 | C |
| ENLC | EnLink Midstream, LLC | Q4 2015 | 2016-02-17 | C+ |
| JJSF | J&J Snack Foods Corp. | Q1 2016 | 2016-01-26 | C |
DUOT · Q4 2023 → YESThe question is: Does management describe that MORE THAN ONE INDEPENDENT OUTSIDE PARTY has RECENTLY put something real of its own behind this company — money, orders, capacity, reputation, approval, o...NO The transcript mentions new AI subscription and support services contracts with two major railroads, which are concrete recent actions by two independent outside parties. However, management describes these as "just the beginning," indicating that the business implied is early relative to the company's reported size. This meets the criteria for YES under the specific conditions provided but the overall context of poor financials and the need for capital infusion suggests the actions may not fully align with the "validating a trajectory whose contribution is still mostly ahead" aspect in a way that overrides the NO criteria for rescue financing or balance-sheet repair. The patent grant is an approval but not a party putting money or orders behind the company in the required sense. Partnerships with Dell and NVIDIA are strengthened but not new concrete actions costing to reverse. Thus, the answer is NO.
TENB · Q2 2021 → YESThe question is about whether management describes more than one independent outside party recently putting something real behind the company, and treating this as validating a trajectory still mostly...YES The transcript shows management describing multiple independent outside parties taking concrete recent actions that validate the company's trajectory as still early relative to reported results. Specifically, NIST selected Tenable as one of 18 technologies for its Zero Trust initiative, granting formal approval and admission. Separately, the company entered a $375 million credit agreement with lenders to support growth, providing capital backing. These actions—approval and investment—are treated by management as endorsements of the business's early-stage potential, with references to ongoing deployments and pipeline activity in areas like OT and AD that exceed the current reported size. The parties are independent, and the actions are recent and in motion rather than reflective of fully realized results.
CRGO · Q1 2024 → YESThe question is: Does management describe that MORE THAN ONE INDEPENDENT OUTSIDE PARTY has RECENTLY put something real of its own behind this company — money, orders, capacity, reputation, approval, o...NO The transcript describes partnerships or expansions with United Airlines, Delta Cargo, Singapore Airlines, and Fits Cargo, but these are presented as ongoing or expanding relationships rather than new, concrete recent actions from multiple independent parties that validate an early-stage trajectory. The United Airlines example is a specific commitment to build a portal, yet the 49 carrier sellers and new additions are framed as rollouts already reflected in results, with pipeline mentions indicating future activity. Management connects these to growth but does not clearly treat the convergence as validating a trajectory mostly ahead of reported results in a way that meets the criteria for multiple independent endorsements with costly commitments.